We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Synthetic Biology – News and Features

News

Codon Devices Signs Distribution Agreement with Open Biosystems

Open Biosystems will distribute Codon Devices’ gene synthesis offering in North America.
News

deCODE biostructures Announces Collaborative Research Agreement with Institut de Recherche Servier

The research collaboration provides Servier with access to deCODE’s expertise in de novo protein crystal structure determination.
News

deCODE biostructures Initiates Research Collaboration with Genus Onocology

Under the agreement, deCODE will conduct gene to structure research on protein targets for Genus Oncology.
News

J. Craig Venter Institute Announces Management Team and Organizational Structure

The Institute will no longer be organized under the two research divisions TIGR and TCAG, but will now encompass an administrative team and several research groups.
News

CODA and Integrated Genomics Announce Collaboration to Enhance Protein Expression Services

The collaboration creates a protocol that uses IG’s Pichia yeast expression system with Coda translational protein expression.
News

Invitrogen and Blue Heron Biotechnology Enter into Strategic Development and Distribution Relationship

Invitrogen will invest in Blue Heron in exchange for worldwide rights to distribute Blue Heron's custom gene synthesis services.
News

Glimpse the Future in Synthetic Biology, Cancer and Stem Cells at MASS Opportunities

MASSOpportunities will take place on November 2 at the Hilton Boston Logan Airport, Boston, MA.
News

Sloning Launches with the Production of Synthetic Genes

Company produces synthetic genes using the Slonomics™ technology.
News

CODA Genomics Closes $1.6 Million Series B Financing

Investors believe that CODA’s Translation Engineering™ solves many problems of protein expression.
News

Synthetic Biology Promises to Shape the Future of Life Sciences

Drug applications discovered through synthetic biology have streamlined the pharmaceutical industry’s ability to deliver new therapeutic agents.
Advertisement